PPD's white paper highlights the importance of effective pharmacovigilance (PV) regulatory intelligence (RI) in drug and medical device development. It emphasizes the role of functional service provider (FSP) partnerships in ensuring accurate, cost-effective PV RI across global markets. PPD's proprietary RegView platform aids in monitoring, analyzing, and interpreting regulations, while their PV RI team provides expert guidance on adapting to regulatory changes. With over 25 years of experience, PPD ensures compliance and supports successful product development through comprehensive PV RI solutions, maintaining regulatory intelligence for nearly 100 countries and supporting over 250 clients.

Join for free to read